S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Endometrial Cancer
Interventions: DRUG: medroxyprogesterone|DRUG: tamoxifen citrate|PROCEDURE: adjuvant therapy
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)|Cancer and Leukemia Group B